{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:31:07Z","timestamp":1790487067943,"version":"4.1.0"},"publisher-location":"Cham","reference-count":81,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319977454","type":"print"},{"value":"9783319977461","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-97746-1_6","type":"book-chapter","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T13:51:34Z","timestamp":1541685094000},"page":"97-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Preservation of Quiescent Chronic Myelogenous Leukemia Stem Cells by the Bone Marrow Microenvironment"],"prefix":"10.1007","author":[{"given":"Mansi","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,9]]},"reference":[{"issue":"17","key":"6_CR1","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"CL Sawyers","year":"1999","unstructured":"Sawyers CL (1999) Chronic myeloid leukemia. N Engl J Med 340(17):1330\u20131340. PubMed PMID: 10219069","journal-title":"N Engl J Med"},{"issue":"23","key":"6_CR2","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA (2006) Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355(23):2408\u20132417. PubMed PMID: 17151364","journal-title":"N Engl J Med"},{"key":"6_CR3","doi-asserted-by":"crossref","unstructured":"Chu S, McDonald T, Lin A, Chakraborty S, Huang Q, Snyder DS, Bhatia R (2011) Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment. Blood. Epub 2011\/09\/21. doi:blood-2010-12-327437 [pii] 10.1182\/blood-2010-12-327437. PubMed PMID: 21931114","DOI":"10.1182\/blood-2010-12-327437"},{"issue":"8","key":"6_CR4","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1182\/blood-2003-04-1271","volume":"103","author":"S Chu","year":"2004","unstructured":"Chu S, Holtz M, Gupta M, Bhatia R (2004) BCR\/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells. Blood 103(8):3167\u20133174. PubMed PMID: 15070699","journal-title":"Blood"},{"issue":"1","key":"6_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"AS Corbin","year":"2011","unstructured":"Corbin AS, Agarwal A, Loriaux M, Cortes J, Deininger MW, Druker BJ (2011) Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest 121(1):396\u2013409. PubMed PMID: 21157039","journal-title":"J Clin Invest"},{"issue":"1","key":"6_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham SM, Jorgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, Holyoake TL (2002) Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99(1):319\u2013325. PubMed PMID: 11756187","journal-title":"Blood"},{"issue":"10","key":"6_CR7","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1182\/blood.V99.10.3792","volume":"99","author":"MS Holtz","year":"2002","unstructured":"Holtz MS, Slovak ML, Zhang F, Sawyers CL, Forman SJ, Bhatia R (2002) Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation. Blood 99(10):3792\u20133800. PubMed PMID: 11986238","journal-title":"Blood"},{"issue":"10","key":"6_CR8","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","volume":"121","author":"B Zhang","year":"2013","unstructured":"Zhang B, Li M, McDonald T, Holyoake TL, Moon RT, Campana D, Shultz L, Bhatia R (2013) Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-beta-catenin signaling. Blood 121(10):1824\u20131838. \nhttps:\/\/doi.org\/10.1182\/blood-2012-02-412890\n\n. PubMed PMID: 23299311; PMCID: PMC3591802","journal-title":"Blood"},{"issue":"1","key":"6_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1182\/asheducation-2017.1.115","volume":"2017","author":"R Bhatia","year":"2017","unstructured":"Bhatia R (2017) Novel approaches to therapy in CML. Hematol Am Soc Hematol Educ Program 2017(1):115\u2013120. Epub 2017\/12\/10. \nhttps:\/\/doi.org\/10.1182\/asheducation-2017.1.115\n\n. PubMed PMID: 29222245","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"11","key":"6_CR10","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","volume":"11","author":"FX Mahon","year":"2010","unstructured":"Mahon FX, Rea D, Guilhot J, Guilhot F, Huguet F, Nicolini F, Legros L, Charbonnier A, Guerci A, Varet B, Etienne G, Reiffers J, Rousselot P (2010) Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol 11(11):1029\u20131035. PubMed PMID: 20965785","journal-title":"Lancet Oncol"},{"issue":"4","key":"6_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1182\/blood-2013-02-483750","volume":"122","author":"DM Ross","year":"2013","unstructured":"Ross DM, Branford S, Seymour JF, Schwarer AP, Arthur C, Yeung DT, Dang P, Goyne JM, Slader C, Filshie RJ, Mills AK, Melo JV, White DL, Grigg AP, Hughes TP (2013) Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study. Blood 122(4):515\u2013522. \nhttps:\/\/doi.org\/10.1182\/blood-2013-02-483750\n\n. PubMed PMID: 23704092","journal-title":"Blood"},{"issue":"1-2","key":"6_CR12","first-page":"7","volume":"4","author":"R Schofield","year":"1978","unstructured":"Schofield R (1978) The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4(1-2):7\u201325. Epub 1978\/01\/01. PubMed PMID: 747780","journal-title":"Blood Cells"},{"issue":"7483","key":"6_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12984","volume":"505","author":"SJ Morrison","year":"2014","unstructured":"Morrison SJ, Scadden DT (2014) The bone marrow niche for haematopoietic stem cells. Nature 505(7483):327\u2013334. \nhttps:\/\/doi.org\/10.1038\/nature12984\n\n. PubMed PMID: 24429631; PMCID: PMC4514480","journal-title":"Nature"},{"issue":"3","key":"6_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1084\/jem.20110994","volume":"209","author":"A Mansour","year":"2012","unstructured":"Mansour A, Abou-Ezzi G, Sitnicka E, Jacobsen SE, Wakkach A, Blin-Wakkach C (2012) Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow. J Exp Med 209(3):537\u2013549. Epub 2012\/02\/22. \nhttps:\/\/doi.org\/10.1084\/jem.20110994\n\n. PubMed PMID: 22351931; PMCID: PMC3302238","journal-title":"J Exp Med"},{"issue":"9","key":"6_CR15","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1182\/blood-2003-11-4011","volume":"103","author":"D Visnjic","year":"2004","unstructured":"Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL (2004) Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103(9):3258\u20133264. Epub 2004\/01\/17. \nhttps:\/\/doi.org\/10.1182\/blood-2003-11-4011\n\n. PubMed PMID: 14726388","journal-title":"Blood"},{"issue":"6960","key":"6_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425(6960):841\u2013846. Epub 2003\/10\/24. \nhttps:\/\/doi.org\/10.1038\/nature02040\n\n. PubMed PMID: 14574413","journal-title":"Nature"},{"issue":"6960","key":"6_CR17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nature02041","volume":"425","author":"J Zhang","year":"2003","unstructured":"Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L (2003) Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425(6960):836\u2013841. Epub 2003\/10\/24. \nhttps:\/\/doi.org\/10.1038\/nature02041\n\n. PubMed PMID: 14574412","journal-title":"Nature"},{"issue":"2","key":"6_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2004.07.004","volume":"118","author":"F Arai","year":"2004","unstructured":"Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T (2004) Tie2\/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118(2):149\u2013161. Epub 2004\/07\/21. \nhttps:\/\/doi.org\/10.1016\/j.cell.2004.07.004\n\n. PubMed PMID: 15260986","journal-title":"Cell"},{"issue":"4","key":"6_CR19","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1182\/blood-2004-11-4422","volume":"106","author":"SK Nilsson","year":"2005","unstructured":"Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, Bertoncello I, Bendall LJ, Simmons PJ, Haylock DN (2005) Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106(4):1232\u20131239. Epub 2005\/04\/23. \nhttps:\/\/doi.org\/10.1182\/blood-2004-11-4422\n\n. PubMed PMID: 15845900","journal-title":"Blood"},{"issue":"7440","key":"6_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature11926","volume":"495","author":"A Greenbaum","year":"2013","unstructured":"Greenbaum A, Hsu YM, Day RB, Schuettpelz LG, Christopher MJ, Borgerding JN, Nagasawa T, Link DC (2013) CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 495(7440):227\u2013230. \nhttps:\/\/doi.org\/10.1038\/nature11926\n\n. PubMed PMID: 23434756; PMCID: PMC3600148","journal-title":"Nature"},{"issue":"7440","key":"6_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature11885","volume":"495","author":"L Ding","year":"2013","unstructured":"Ding L, Morrison SJ (2013) Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495(7440):231\u2013235. \nhttps:\/\/doi.org\/10.1038\/nature11885\n\n. PubMed PMID: 23434755; PMCID: PMC3600153","journal-title":"Nature"},{"issue":"7308","key":"6_CR22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma\u2019ayan A, Enikolopov GN, Frenette PS (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466(7308):829\u2013834. Epub 2010\/08\/13. \nhttps:\/\/doi.org\/10.1038\/nature09262\n\n. PubMed PMID: 20703299; PMCID: PMC3146551","journal-title":"Nature"},{"issue":"2","key":"6_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cell.2005.10.041","volume":"124","author":"Y Katayama","year":"2006","unstructured":"Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, Frenette PS (2006) Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124(2):407\u2013421. Epub 2006\/01\/28. \nhttps:\/\/doi.org\/10.1016\/j.cell.2005.10.041\n\n. PubMed PMID: 16439213","journal-title":"Cell"},{"issue":"7473","key":"6_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature12612","volume":"502","author":"Y Kunisaki","year":"2013","unstructured":"Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, Mizoguchi T, Wei Q, Lucas D, Ito K, Mar JC, Bergman A, Frenette PS (2013) Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502(7473):637\u2013643. Epub 2013\/10\/11. \nhttps:\/\/doi.org\/10.1038\/nature12612\n\n. PubMed PMID: 24107994; PMCID: PMC3821873","journal-title":"Nature"},{"issue":"6","key":"6_CR25","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","volume":"25","author":"T Sugiyama","year":"2006","unstructured":"Sugiyama T, Kohara H, Noda M, Nagasawa T (2006) Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25(6):977\u2013988. Epub 2006\/12\/19. doi:S1074-7613(06)00515-2 [pii]10.1016\/j.immuni.2006.10.016. PubMed PMID: 17174120","journal-title":"Immunity"},{"issue":"3","key":"6_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.immuni.2010.08.017","volume":"33","author":"Y Omatsu","year":"2010","unstructured":"Omatsu Y, Sugiyama T, Kohara H, Kondoh G, Fujii N, Kohno K, Nagasawa T (2010) The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 33(3):387\u2013399. Epub 2010\/09\/21. \nhttps:\/\/doi.org\/10.1016\/j.immuni.2010.08.017\n\n. PubMed PMID: 20850355","journal-title":"Immunity"},{"issue":"7382","key":"6_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10783","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding L, Saunders TL, Enikolopov G, Morrison SJ (2012) Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481(7382):457\u2013462. \nhttps:\/\/doi.org\/10.1038\/nature10783\n\n. PubMed PMID: 22281595; PMCID: PMC3270376","journal-title":"Nature"},{"issue":"11","key":"6_CR28","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/nm.2969","volume":"18","author":"IG Winkler","year":"2012","unstructured":"Winkler IG, Barbier V, Nowlan B, Jacobsen RN, Forristal CE, Patton JT, Magnani JL, Levesque JP (2012) Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance. Nat Med 18(11):1651\u20131657. Epub 2012\/10\/23. \nhttps:\/\/doi.org\/10.1038\/nm.2969\n\n. PubMed PMID: 23086476","journal-title":"Nat Med"},{"issue":"5","key":"6_CR29","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2011.09.053","volume":"147","author":"S Yamazaki","year":"2011","unstructured":"Yamazaki S, Ema H, Karlsson G, Yamaguchi T, Miyoshi H, Shioda S, Taketo MM, Karlsson S, Iwama A, Nakauchi H (2011) Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 147(5):1146\u20131158. Epub 2011\/11\/29. \nhttps:\/\/doi.org\/10.1016\/j.cell.2011.09.053\n\n. PubMed PMID: 22118468","journal-title":"Cell"},{"issue":"6","key":"6_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nm.3155","volume":"19","author":"D Lucas","year":"2013","unstructured":"Lucas D, Scheiermann C, Chow A, Kunisaki Y, Bruns I, Barrick C, Tessarollo L, Frenette PS (2013) Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration. Nat Med 19(6):695\u2013703. Epub 2013\/05\/07. \nhttps:\/\/doi.org\/10.1038\/nm.3155\n\n. PubMed PMID: 23644514; PMCID: PMC3964478","journal-title":"Nat Med"},{"issue":"4","key":"6_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.5312\/wjo.v4.i4.198","volume":"4","author":"T Miyamoto","year":"2013","unstructured":"Miyamoto T (2013) Role of osteoclasts in regulating hematopoietic stem and progenitor cells. World J Orthop 4(4):198\u2013206. Epub 2013\/10\/23. \nhttps:\/\/doi.org\/10.5312\/wjo.v4.i4.198\n\n. PubMed PMID: 24147255; PMCID: PMC3801239","journal-title":"World J Orthop"},{"issue":"5","key":"6_CR32","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1182\/blood-2010-05-282855","volume":"117","author":"S Lymperi","year":"2011","unstructured":"Lymperi S, Ersek A, Ferraro F, Dazzi F, Horwood NJ (2011) Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood 117(5):1540\u20131549. Epub 2010\/12\/07. \nhttps:\/\/doi.org\/10.1182\/blood-2010-05-282855\n\n. PubMed PMID: 21131587","journal-title":"Blood"},{"issue":"2","key":"6_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nbt1281","volume":"25","author":"GB Adams","year":"2007","unstructured":"Adams GB, Martin RP, Alley IR, Chabner KT, Cohen KS, Calvi LM, Kronenberg HM, Scadden DT (2007) Therapeutic targeting of a stem cell niche. Nat Biotechnol 25(2):238\u2013243. Epub 2007\/01\/24. \nhttps:\/\/doi.org\/10.1038\/nbt1281\n\n. PubMed PMID: 17237769","journal-title":"Nat Biotechnol"},{"issue":"7350","key":"6_CR34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10160","volume":"474","author":"J Fujisaki","year":"2011","unstructured":"Fujisaki J, Wu J, Carlson AL, Silberstein L, Putheti P, Larocca R, Gao W, Saito TI, Lo Celso C, Tsuyuzaki H, Sato T, Cote D, Sykes M, Strom TB, Scadden DT, Lin CP (2011) In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474(7350):216\u2013219. Epub 2011\/06\/10. \nhttps:\/\/doi.org\/10.1038\/nature10160\n\n. PubMed PMID: 21654805; PMCID: PMC3725645","journal-title":"Nature"},{"issue":"3","key":"6_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.stem.2018.01.017","volume":"22","author":"Y Hirata","year":"2018","unstructured":"Hirata Y, Furuhashi K, Ishii H, Li HW, Pinho S, Ding L, Robson SC, Frenette PS, Fujisaki J (2018) CD150(high) bone marrow tregs maintain hematopoietic stem cell quiescence and immune privilege via adenosine. Cell Stem Cell 22(3):445\u201353 e5. Epub 2018\/02\/20. \nhttps:\/\/doi.org\/10.1016\/j.stem.2018.01.017\n\n. PubMed PMID: 29456159","journal-title":"Cell Stem Cell"},{"issue":"2","key":"6_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1084\/jem.20101688","volume":"208","author":"A Chow","year":"2011","unstructured":"Chow A, Lucas D, Hidalgo A, Mendez-Ferrer S, Hashimoto D, Scheiermann C, Battista M, Leboeuf M, Prophete C, van Rooijen N, Tanaka M, Merad M, Frenette PS (2011) Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 208(2):261\u2013271. Epub 2011\/02\/02. \nhttps:\/\/doi.org\/10.1084\/jem.20101688\n\n. PubMed PMID: 21282381; PMCID: PMC3039855","journal-title":"J Exp Med"},{"issue":"11","key":"6_CR37","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/nm.3707","volume":"20","author":"I Bruns","year":"2014","unstructured":"Bruns I, Lucas D, Pinho S, Ahmed J, Lambert MP, Kunisaki Y, Scheiermann C, Schiff L, Poncz M, Bergman A, Frenette PS (2014) Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat Med 20(11):1315\u20131320. Epub 2014\/10\/20. \nhttps:\/\/doi.org\/10.1038\/nm.3707\n\n. PubMed PMID: 25326802; PMCID: PMC4258871","journal-title":"Nat Med"},{"issue":"6128","key":"6_CR38","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/328342a0","volume":"328","author":"MY Gordon","year":"1987","unstructured":"Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF (1987) Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328(6128):342\u2013344. Epub 1987\/07\/23. \nhttps:\/\/doi.org\/10.1038\/328342a0\n\n. PubMed PMID: 3474529","journal-title":"Nature"},{"issue":"11","key":"6_CR39","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/nm.3364","volume":"19","author":"DS Krause","year":"2013","unstructured":"Krause DS, Fulzele K, Catic A, Sun CC, Dombkowski D, Hurley MP, Lezeau S, Attar E, Wu JY, Lin HY, Divieti-Pajevic P, Hasserjian RP, Schipani E, Van Etten RA, Scadden DT (2013) Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nat Med 19(11):1513\u20131517. Epub 2013\/10\/29. \nhttps:\/\/doi.org\/10.1038\/nm.3364\n\n. PubMed PMID: 24162813; PMCID: PMC3827980","journal-title":"Nat Med"},{"issue":"10","key":"6_CR40","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1182\/blood-2011-03-345165","volume":"118","author":"SW Lane","year":"2011","unstructured":"Lane SW, Wang YJ, Lo Celso C, Ragu C, Bullinger L, Sykes SM, Ferraro F, Shterental S, Lin CP, Gilliland DG, Scadden DT, Armstrong SA, Williams DA (2011) Differential niche and Wnt requirements during acute myeloid leukemia progression. Blood 118(10):2849\u20132856. Epub 2011\/07\/19. \nhttps:\/\/doi.org\/10.1182\/blood-2011-03-345165\n\n. PubMed PMID: 21765021; PMCID: PMC3172801","journal-title":"Blood"},{"issue":"10","key":"6_CR41","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/nm1489","volume":"12","author":"DS Krause","year":"2006","unstructured":"Krause DS, Lazarides K, von Andrian UH, Van Etten RA (2006) Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med 12(10):1175\u20131180. PubMed PMID: 16998483","journal-title":"Nat Med"},{"issue":"9","key":"6_CR42","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1182\/blood-2013-11-538694","volume":"123","author":"DS Krause","year":"2014","unstructured":"Krause DS, Lazarides K, Lewis JB, von Andrian UH, Van Etten RA (2014) Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche. Blood 123(9):1361\u20131371. Epub 2014\/01\/08. \nhttps:\/\/doi.org\/10.1182\/blood-2013-11-538694\n\n. PubMed PMID: 24394666; PMCID: PMC3938148","journal-title":"Blood"},{"issue":"5909","key":"6_CR43","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1126\/science.1164390","volume":"322","author":"A Colmone","year":"2008","unstructured":"Colmone A, Amorim M, Pontier AL, Wang S, Jablonski E, Sipkins DA (2008) Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science (New York, NY) 322(5909):1861\u20131865. Epub 2008\/12\/20. \nhttps:\/\/doi.org\/10.1126\/science.1164390\n\n. PubMed PMID: 19095944","journal-title":"Science (New York, NY)"},{"issue":"18","key":"6_CR44","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1182\/blood-2009-03-208181","volume":"114","author":"Q Zhou","year":"2009","unstructured":"Zhou Q, Bucher C, Munger ME, Highfill SL, Tolar J, Munn DH, Levine BL, Riddle M, June CH, Vallera DA, Weigel BJ, Blazar BR (2009) Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia. Blood 114(18):3793\u20133802. Epub 2009\/09\/03. \nhttps:\/\/doi.org\/10.1182\/blood-2009-03-208181\n\n. PubMed PMID: 19724059; PMCID: PMC2773484","journal-title":"Blood"},{"issue":"4","key":"6_CR45","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","volume":"21","author":"B Zhang","year":"2012","unstructured":"Zhang B, Ho YW, Huang Q, Maeda T, Lin A, Lee SU, Hair A, Holyoake TL, Huettner C, Bhatia R (2012) Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell 21(4):577\u2013592. \nhttps:\/\/doi.org\/10.1016\/j.ccr.2012.02.018\n\n. PubMed PMID: 22516264; PMCID: 3332001","journal-title":"Cancer Cell"},{"issue":"3","key":"6_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","volume":"13","author":"K Schepers","year":"2013","unstructured":"Schepers K, Pietras EM, Reynaud D, Flach J, Binnewies M, Garg T, Wagers AJ, Hsiao EC, Passegue E (2013) Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13(3):285\u2013299. \nhttps:\/\/doi.org\/10.1016\/j.stem.2013.06.009\n\n. PubMed PMID: 23850243; PMCID: 3769504","journal-title":"Cell Stem Cell"},{"issue":"5","key":"6_CR47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.stem.2010.04.004","volume":"6","author":"Y Shiozawa","year":"2010","unstructured":"Shiozawa Y, Taichman RS (2010) Dysfunctional niches as a root of hematopoietic malignancy. Cell Stem Cell 6(5):399\u2013400. \nhttps:\/\/doi.org\/10.1016\/j.stem.2010.04.004\n\n. PubMed PMID: 20452309","journal-title":"Cell Stem Cell"},{"issue":"7290","key":"6_CR48","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nature08851","volume":"464","author":"MH Raaijmakers","year":"2010","unstructured":"Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA, Ebert BL, Al-Shahrour F, Hasserjian RP, Scadden EO, Aung Z, Matza M, Merkenschlager M, Lin C, Rommens JM, Scadden DT (2010) Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464(7290):852\u2013857. \nhttps:\/\/doi.org\/10.1038\/nature08851\n\n. PubMed PMID: 20305640; PMCID: 3422863","journal-title":"Nature"},{"issue":"6","key":"6_CR49","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.cell.2007.05.014","volume":"129","author":"CR Walkley","year":"2007","unstructured":"Walkley CR, Olsen GH, Dworkin S, Fabb SA, Swann J, McArthur GA, Westmoreland SV, Chambon P, Scadden DT, Purton LE (2007) A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 129(6):1097\u20131110. \nhttps:\/\/doi.org\/10.1016\/j.cell.2007.05.014\n\n. PubMed PMID: 17574023; PMCID: 1974882","journal-title":"Cell"},{"issue":"6","key":"6_CR50","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cell.2007.03.055","volume":"129","author":"CR Walkley","year":"2007","unstructured":"Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH (2007) Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 129(6):1081\u20131095. \nhttps:\/\/doi.org\/10.1016\/j.cell.2007.03.055\n\n. PubMed PMID: 17574022; PMCID: 2768301","journal-title":"Cell"},{"issue":"12","key":"6_CR51","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1182\/blood-2008-03-148999","volume":"112","author":"YW Kim","year":"2008","unstructured":"Kim YW, Koo BK, Jeong HW, Yoon MJ, Song R, Shin J, Jeong DC, Kim SH, Kong YY (2008) Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood 112(12):4628\u20134638. \nhttps:\/\/doi.org\/10.1182\/blood-2008-03-148999\n\n. PubMed PMID: 18818392","journal-title":"Blood"},{"issue":"9","key":"6_CR52","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm909","volume":"9","author":"T Matsunaga","year":"2003","unstructured":"Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, Fujimi A, Akiyama T, Kuroda H, Kawano Y, Kobune M, Kato J, Hirayama Y, Sakamaki S, Kohda K, Miyake K, Niitsu Y (2003) Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 9(9):1158\u20131165. Epub 2003\/08\/05. \nhttps:\/\/doi.org\/10.1038\/nm909\n\n. PubMed PMID: 12897778","journal-title":"Nat Med"},{"issue":"4","key":"6_CR53","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/sj.leu.2402431","volume":"16","author":"C Voermans","year":"2002","unstructured":"Voermans C, van Heese WP, de Jong I, Gerritsen WR, van Der Schoot CE (2002) Migratory behavior of leukemic cells from acute myeloid leukemia patients. Leukemia 16(4):650\u2013657. Epub 2002\/04\/18. \nhttps:\/\/doi.org\/10.1038\/sj.leu.2402431\n\n. PubMed PMID: 11960346","journal-title":"Leukemia"},{"issue":"4","key":"6_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.stem.2011.07.017","volume":"9","author":"TC Luis","year":"2011","unstructured":"Luis TC, Naber BA, Roozen PP, Brugman MH, de Haas EF, Ghazvini M, Fibbe WE, van Dongen JJ, Fodde R, Staal FJ (2011) Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. Cell Stem Cell 9(4):345\u2013356. Epub 2011\/10\/11. \nhttps:\/\/doi.org\/10.1016\/j.stem.2011.07.017\n\n. PubMed PMID: 21982234","journal-title":"Cell Stem Cell"},{"issue":"46","key":"6_CR55","doi-asserted-by":"publisher","first-page":"17967","DOI":"10.1073\/pnas.0808303105","volume":"105","author":"Y Minami","year":"2008","unstructured":"Minami Y, Stuart SA, Ikawa T, Jiang Y, Banno A, Hunton IC, Young DJ, Naoe T, Murre C, Jamieson CH, Wang JY (2008) BCR-ABL-transformed GMP as myeloid leukemic stem cells. Proc Natl Acad Sci U S A 105(46):17967\u201317972. PubMed PMID: 19004799","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"6_CR56","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CH Jamieson","year":"2004","unstructured":"Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A, Sawyers CL, Weissman IL (2004) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351(7):657\u2013667. PubMed PMID: 15306667","journal-title":"N Engl J Med"},{"issue":"6","key":"6_CR57","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","volume":"12","author":"C Zhao","year":"2007","unstructured":"Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM, Lagoo A, Reya T (2007) Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12(6):528\u2013541. Epub 2007\/12\/11. doi:S1535-6108(07)00334-0 [pii]10.1016\/j.ccr.2007.11.003. PubMed PMID: 18068630; PMCID: 2262869.","journal-title":"Cancer Cell"},{"issue":"1","key":"6_CR58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/leu.2008.262","volume":"23","author":"Y Hu","year":"2009","unstructured":"Hu Y, Chen Y, Douglas L, Li S (2009) beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia 23(1):109\u2013116. Epub 2008\/09\/27. \nhttps:\/\/doi.org\/10.1038\/leu.2008.262\n\n. PubMed PMID: 18818703","journal-title":"Leukemia"},{"issue":"4","key":"6_CR59","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.stem.2012.02.017","volume":"10","author":"FH Heidel","year":"2012","unstructured":"Heidel FH, Bullinger L, Feng Z, Wang Z, Neff TA, Stein L, Kalaitzidis D, Lane SW, Armstrong SA (2012) Genetic and pharmacologic inhibition of beta-catenin targets imatinib-resistant leukemia stem cells in CML. Cell Stem Cell 10(4):412\u2013424. Epub 2012\/04\/10. doi:S1934-5909(12)00076-8 [pii]10.1016\/j.stem.2012.02.017. PubMed PMID: 22482506; PMCID: 3339412","journal-title":"Cell Stem Cell"},{"issue":"5","key":"6_CR60","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/sj.emboj.7601485","volume":"26","author":"AM Coluccia","year":"2007","unstructured":"Coluccia AM, Vacca A, Dunach M, Mologni L, Redaelli S, Bustos VH, Benati D, Pinna LA, Gambacorti-Passerini C (2007) Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. EMBO J 26(5):1456\u20131466. Epub 2007\/02\/24. doi:7601485 [pii]10.1038\/sj.emboj.7601485. PubMed PMID: 17318191; PMCID: 1817619","journal-title":"EMBO J"},{"issue":"13","key":"6_CR61","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-06-0025","volume":"66","author":"AK Samanta","year":"2006","unstructured":"Samanta AK, Lin H, Sun T, Kantarjian H, Arlinghaus RB (2006) Janus kinase 2: a critical target in chronic myelogenous leukemia. Cancer Res 66(13):6468\u20136472. PubMed PMID: 16818614","journal-title":"Cancer Res"},{"issue":"6","key":"6_CR62","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.stem.2009.03.015","volume":"4","author":"J Gao","year":"2009","unstructured":"Gao J, Graves S, Koch U, Liu S, Jankovic V, Buonamici S, El Andaloussi A, Nimer SD, Kee BL, Taichman R, Radtke F, Aifantis I (2009) Hedgehog signaling is dispensable for adult hematopoietic stem cell function. Cell Stem Cell 4(6):548\u2013558. \nhttps:\/\/doi.org\/10.1016\/j.stem.2009.03.015\n\n. PubMed PMID: 19497283; PMCID: 2914688","journal-title":"Cell Stem Cell"},{"issue":"6","key":"6_CR63","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.stem.2009.03.016","volume":"4","author":"I Hofmann","year":"2009","unstructured":"Hofmann I, Stover EH, Cullen DE, Mao J, Morgan KJ, Lee BH, Kharas MG, Miller PG, Cornejo MG, Okabe R, Armstrong SA, Ghilardi N, Gould S, de Sauvage FJ, McMahon AP, Gilliland DG (2009) Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell 4(6):559\u2013567. \nhttps:\/\/doi.org\/10.1016\/j.stem.2009.03.016\n\n. PubMed PMID: 19497284; PMCID: 3065323","journal-title":"Cell Stem Cell"},{"issue":"3","key":"6_CR64","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","volume":"14","author":"C Dierks","year":"2008","unstructured":"Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P, Trussell C, Schmitt-Graeff A, Landwerlin K, Veelken H, Warmuth M (2008) Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 14(3):238\u2013249. Epub 2008\/09\/06. doi:S1535-6108(08)00257-2 [pii]10.1016\/j.ccr.2008.08.003. PubMed PMID: 18772113","journal-title":"Cancer Cell"},{"issue":"7239","key":"6_CR65","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C Zhao","year":"2009","unstructured":"Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D, Munchhof M, VanArsdale T, Beachy PA, Reya T (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458(7239):776\u2013779. \nhttps:\/\/doi.org\/10.1038\/nature07737\n\n. PubMed PMID: 19169242; PMCID: 2946231","journal-title":"Nature"},{"issue":"10","key":"6_CR66","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1182\/blood-2011-10-383752","volume":"119","author":"DA Irvine","year":"2012","unstructured":"Irvine DA, Copland M (2012) Targeting hedgehog in hematologic malignancy. Blood 119(10):2196\u20132204. \nhttps:\/\/doi.org\/10.1182\/blood-2011-10-383752\n\n. PubMed PMID: 22223823","journal-title":"Blood"},{"issue":"1","key":"6_CR67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/nyas.12562","volume":"1335","author":"AG Evans","year":"2015","unstructured":"Evans AG, Calvi LM (2015) Notch signaling in the malignant bone marrow microenvironment: implications for a niche-based model of oncogenesis. Ann N Y Acad Sci 1335(1):63\u201377. \nhttps:\/\/doi.org\/10.1111\/nyas.12562\n\n. PubMed PMID: 25351294; PMCID: 4289406","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"6_CR68","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1182\/blood-2016-05-714089","volume":"129","author":"P Agarwal","year":"2017","unstructured":"Agarwal P, Zhang B, Ho Y, Cook A, Li L, Mikhail FM, Wang Y, McLaughlin ME, Bhatia R (2017) Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI. Blood 129(8):1008\u20131020. Epub 2016\/12\/25. \nhttps:\/\/doi.org\/10.1182\/blood-2016-05-714089\n\n. PubMed PMID: 28011678; PMCID: PMC5324714","journal-title":"Blood"},{"issue":"31","key":"6_CR69","doi-asserted-by":"publisher","first-page":"30487","DOI":"10.18632\/oncotarget.5890","volume":"6","author":"BZ Carter","year":"2015","unstructured":"Carter BZ, Mak PY, Mak DH, Ruvolo VR, Schober W, McQueen T, Cortes J, Kantarjian HM, Champlin RE, Konopleva M, Andreeff M (2015) Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells. Oncotarget 6(31):30487\u201330499. Epub 2015\/10\/03. \nhttps:\/\/doi.org\/10.18632\/oncotarget.5890\n\n. PubMed PMID: 26431162; PMCID: PMC4741546","journal-title":"Oncotarget"},{"issue":"2","key":"6_CR70","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","volume":"21","author":"L Li","year":"2012","unstructured":"Li L, Wang L, Li L, Wang Z, Ho Y, McDonald T, Holyoake TL, Chen W, Bhatia R (2012) Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell 21(2):266\u2013281. \nhttps:\/\/doi.org\/10.1016\/j.ccr.2011.12.020\n\n. PubMed PMID: 22340598; PMCID: PMC3285436","journal-title":"Cancer Cell"},{"issue":"7607","key":"6_CR71","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature18288","volume":"534","author":"SA Abraham","year":"2016","unstructured":"Abraham SA, Hopcroft LE, Carrick E, Drotar ME, Dunn K, Williamson AJ, Korfi K, Baquero P, Park LE, Scott MT, Pellicano F, Pierce A, Copland M, Nourse C, Grimmond SM, Vetrie D, Whetton AD, Holyoake TL (2016) Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells. Nature 534(7607):341\u2013346. Epub 2016\/06\/10. \nhttps:\/\/doi.org\/10.1038\/nature18288\n\n. PubMed PMID: 27281222; PMCID: PMC4913876","journal-title":"Nature"},{"issue":"5","key":"6_CR72","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccr.2010.03.011","volume":"17","author":"B Zhang","year":"2010","unstructured":"Zhang B, Strauss AC, Chu S, Li M, Ho Y, Shiang KD, Snyder DS, Huettner CS, Shultz L, Holyoake T, Bhatia R (2010) Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell 17(5):427\u2013442. Epub 2010\/05\/19. doi:S1535-6108(10)00102-9 [pii]10.1016\/j.ccr.2010.03.011. PubMed PMID: 20478526; PMCID: PMC2873971","journal-title":"Cancer Cell"},{"issue":"11","key":"6_CR73","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/2159-8290.CD-16-0263","volume":"6","author":"MT Scott","year":"2016","unstructured":"Scott MT, Korfi K, Saffrey P, Hopcroft LE, Kinstrie R, Pellicano F, Guenther C, Gallipoli P, Cruz M, Dunn K, Jorgensen HG, Cassels JE, Hamilton A, Crossan A, Sinclair A, Holyoake TL, Vetrie D (2016) Epigenetic reprogramming sensitizes CML stem cells to combined EZH2 and tyrosine kinase inhibition. jCancer Discov 6(11):1248\u20131257. Epub 2016\/11\/04. \nhttps:\/\/doi.org\/10.1158\/2159-8290.CD-16-0263\n\n. PubMed PMID: 27630125","journal-title":"jCancer Discov"},{"issue":"9","key":"6_CR74","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1182\/blood-2013-12-545640","volume":"124","author":"P Gallipoli","year":"2014","unstructured":"Gallipoli P, Cook A, Rhodes S, Hopcroft L, Wheadon H, Whetton AD, Jorgensen HG, Bhatia R, Holyoake TL (2014) JAK2\/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo. Blood 124(9):1492\u20131501. \nhttps:\/\/doi.org\/10.1182\/blood-2013-12-545640\n\n. PubMed PMID: 24957147; PMCID: PMC4148771","journal-title":"Blood"},{"issue":"10","key":"6_CR75","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1172\/JCI68951","volume":"123","author":"P Neviani","year":"2013","unstructured":"Neviani P, Harb JG, Oaks JJ, Santhanam R, Walker CJ, Ellis JJ, Ferenchak G, Dorrance AM, Paisie CA, Eiring AM, Ma Y, Mao HC, Zhang B, Wunderlich M, May PC, Sun C, Saddoughi SA, Bielawski J, Blum W, Klisovic RB, Solt JA, Byrd JC, Volinia S, Cortes J, Huettner CS, Koschmieder S, Holyoake TL, Devine S, Caligiuri MA, Croce CM, Garzon R, Ogretmen B, Arlinghaus RB, Chen CS, Bittman R, Hokland P, Roy DC, Milojkovic D, Apperley J, Goldman JM, Reid A, Mulloy JC, Bhatia R, Marcucci G, Perrotti D (2013) PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest 123(10):4144\u20134157. Epub 2013\/09\/04. \nhttps:\/\/doi.org\/10.1172\/JCI68951\n\n. PubMed PMID: 23999433; PMCID: PMC3784537","journal-title":"J Clin Invest"},{"issue":"19","key":"6_CR76","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1182\/blood-2013-02-485607","volume":"122","author":"P Gallipoli","year":"2013","unstructured":"Gallipoli P, Pellicano F, Morrison H, Laidlaw K, Allan EK, Bhatia R, Copland M, Jorgensen HG, Holyoake TL (2013) Autocrine TNF-alpha production supports CML stem and progenitor cell survival and enhances their proliferation. Blood 122(19):3335\u20133339. \nhttps:\/\/doi.org\/10.1182\/blood-2013-02-485607\n\n. PubMed PMID: 24041577; PMCID: 3953090","journal-title":"Blood"},{"issue":"23","key":"6_CR77","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1182\/blood-2015-11-679928","volume":"128","author":"B. Zhang","year":"2016","unstructured":"Zhang B, Chu S, Agarwal P, Campbell VL, Hopcroft L, Jorgensen HG, Lin A, Gaal K, Holyoake TL, Bhatia R (2016) Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor treated CML stem cells. Blood. \nhttps:\/\/doi.org\/10.1182\/blood-2015-11-679928\n\n. PubMed PMID: 27621307","journal-title":"Blood"},{"issue":"37","key":"6_CR78","doi-asserted-by":"publisher","first-page":"16280","DOI":"10.1073\/pnas.1004408107","volume":"107","author":"M Jaras","year":"2010","unstructured":"Jaras M, Johnels P, Hansen N, Agerstam H, Tsapogas P, Rissler M, Lassen C, Olofsson T, Bjerrum OW, Richter J, Fioretos T (2010) Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein. Proc Natl Acad Sci U S A 107(37):16280\u201316285. Epub 2010\/09\/02. doi:1004408107 [pii]10.1073\/pnas.1004408107. PubMed PMID: 20805474; PMCID: PMC2941341","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR79","doi-asserted-by":"publisher","first-page":"25476","DOI":"10.1038\/srep25476","volume":"6","author":"DA Irvine","year":"2016","unstructured":"Irvine DA, Zhang B, Kinstrie R, Tarafdar A, Morrison H, Campbell VL, Moka HA, Ho Y, Nixon C, Manley PW, Wheadon H, Goodlad JR, Holyoake TL, Bhatia R, Copland M (2016) Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Sci Rep 6:25476. \nhttps:\/\/doi.org\/10.1038\/srep25476\n\n. PubMed PMID: 27157927; PMCID: PMC4860619","journal-title":"Sci Rep"},{"issue":"10","key":"6_CR80","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nm1483","volume":"12","author":"L Jin","year":"2006","unstructured":"Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE (2006) Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12(10):1167\u20131174. Epub 2006\/09\/26. \nhttps:\/\/doi.org\/10.1038\/nm1483\n\n. PubMed PMID: 16998484","journal-title":"Nat Med"},{"issue":"355","key":"6_CR81","doi-asserted-by":"publisher","first-page":"355ra117","DOI":"10.1126\/scitranslmed.aag1180","volume":"8","author":"BZ Carter","year":"2016","unstructured":"Carter BZ, Mak PY, Mu H, Zhou H, Mak DH, Schober W, Leverson JD, Zhang B, Bhatia R, Huang X, Cortes J, Kantarjian H, Konopleva M, Andreeff M (2016) Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells. Sci Transl Med 8(355):355ra117. Epub 2016\/09\/09. \nhttps:\/\/doi.org\/10.1126\/scitranslmed.aag1180\n\n. PubMed PMID: 27605552; PMCID: PMC5111086","journal-title":"Sci Transl Med"}],"container-title":["Advances in Experimental Medicine and Biology","Biological Mechanisms of Minimal Residual Disease and Systemic Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-97746-1_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T13:52:44Z","timestamp":1541685164000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-97746-1_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319977454","9783319977461"],"references-count":81,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-97746-1_6","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}